Siliang Duan

机构：Guangxi Medical University, Guangxi University of Science and Technology · ORCID：0000-0003-4054-9367

发表论文 36 篇 · 总被引 854 次 · h-index 16

代表论文

• The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide (2018 · Theranostics · 被引 104)
• Co-Delivery of Paclitaxel and PLK1-Targeted siRNA Using Aptamer-Functionalized Cationic Liposome for Synergistic Anti-Breast Cancer Effects In Vivo (2019 · Journal of Biomedical Nanotechnology · 被引 98)
• Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy (2021 · Signal Transduction and Targeted Therapy · 被引 81)
• Graphene quantum dots mediated magnetic chitosan drug delivery nanosystems for targeting synergistic photothermal-chemotherapy of hepatocellular carcinoma (2022 · Cancer Biology & Therapy · 被引 52)
• <p>In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice</p> (2020 · International Journal of Nanomedicine · 被引 45)
• Generation of dual functional nanobody-nanoluciferase fusion and its potential in bioluminescence enzyme immunoassay for trace glypican-3 in serum (2021 · Sensors and Actuators B Chemical · 被引 41)